4760 Results

People

  1. Berger
    Berger
  2. Motzer
    Motzer
  3. Giralt
    Giralt
  4. Perales
    Perales
  5. Lee
    Lee
  6. Hudis
    Hudis
  7. Morrow
    Morrow
  8. Levine
    Levine
  9. Reis-Filho
    Reis-Filho
  10. Solit
    Solit

Groups

  1. Department of Medicine (1963)
  2. GSK Faculty (1162)
  3. Solid Tumor Oncology Division (1064)
  4. Surgery (904)
  5. Survivorship Research (795)
  6. Center for Hematologic Malignancies (777)
  7. Sloan Kettering Institute Postdocs (739)
  8. Hematologic Malignancies, Division of (725)
  9. Department of Pathology and Laboratory Medicine (655)
  10. Population Sciences Research Program (574)
  1. "2016"
Formats
  1. Journal Article (2949)
  2. Meeting Abstract (1606)
  3. Book Section (155)
  4. Conference Paper (36)
  5. Book Whole (14)
Groups
  1. Department of Medicine (1963)
  2. GSK Faculty (1162)
  3. Solid Tumor Oncology Division (1064)
  4. Surgery (904)
  5. Survivorship Research (795)
  6. Center for Hematologic Malignancies (777)

More Groups

People
  1. Michael Berger (93)
  2. Jedd Wolchok (84)
  3. Robert Motzer (74)
  4. Sergio Giralt (73)
  5. Miguel-Angel Perales (69)
  6. Jose Baselga (67)

More People

Years
  1. 2016 (4760)
Publications
  1. Journal of Clinical Oncology (469)
  2. Blood (210)
  3. Modern Pathology (124)
  4. Laboratory Investigation (108)
  5. International Journal of Radiation Oncology, Biology, Physics (104)
  6. Annals of Oncology (94)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (497)
  3. Springer (349)
  4. Nature Publishing Group (322)
  5. Oxford University Press (248)
  6. American Society of Hematology (213)

More Publishers

Results (4760)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term overall survival (OS) with nivolumab in previously treated patients with advanced renal cell carcinoma (aRCC) from phase I and II studies
    Meeting Abstract

    McDermott, D. F.; Motzer, R.; Atkins, M. B.; Plimack, E. R.; Sznol, M.; George, S.; Drake, C. G.; Rini, B. I.; Choueiri, T. K.; Kuzel, T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase 1 study of CB-839, a small molecule inhibitor of glutaminase (GLS), alone and in combination with everolimus (E) in patients (pts) with renal cell cancer (RCC)
    Meeting Abstract

    Meric-Bernstam, F.; Tannir, N. M.; Mier, J. W.; DeMichele, A.; Telli, M. L.; Fan, A. C.; Munster, P. N.; Carvajal, R. D.; Orford, K. W.; Bennett, M. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Prognostic significance of DNA damage repair (DDR) mutations in patients with urothelial carcinoma (UC) and associations with tumor infiltrating lymphocytes (TILs)
    Meeting Abstract

    McBride, R. B.; Patel, V. G.; Lorduy, A. C.; Castillo-Martin, M.; Cha, E. K.; Berger, M. F.; Wang, L.; Oh, W. K.; Zhu, J.; Cordon-Cardo, C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders (AD) or major toxicity with ipilimumab (IPI)
    Meeting Abstract

    Menzies, A. M.; Johnson, D. B.; Ramanujam, S.; Atkinson, V.; Wong, A. N. M.; Park, J. J.; McQuade, J. L.; Shoushtari, A. N.; Tsai, K. K.; Eroglu, Z.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Validity of Adjuvant! Online in elderly patients with stage III colon cancer based on 2,794 patients from the ACCENT database
    Meeting Abstract

    Matthaiou, C.; Renfro, L. A.; Papamichael, D.; Yothers, G.; Saltz, L.; Cutsem, E.; Schmoll, H. J.; Labianca, R.; Andre, T.; O'Connell, M. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Characteristics of ponatinib (PON) therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) patients (pts) in real-world (RW) clinical practice compared to the PACE trial
    Meeting Abstract

    Mauro, M. J.; McGarry, L.; Yang, M.; Lustgarten, S.; Huang, H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Comparison of PACE clinical trial versus real-world (RW) ponatinib (PON) prescribing and duration of therapy (DOT) in US chronic-phase chronic myeloid leukemia (CP-CML) patients (pts)
    Meeting Abstract

    Mauro, M. J.; McGarry, L.; Yang, M.; Lustgarten, S.; Huang, H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A clinically applicable molecular-based classification for endometrial cancers
    Meeting Abstract

    McAlpine, J. N.; McConechy, M.; Hoang, L.; Leung, S.; Nakonechny, Q.; Lum, A.; Yang, W. N.; Gilks, C. B.; Huntsman, D.; Talhouk, A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Safety and efficacy of durvalumab (MEDI4736) a PD-L1 antibody, in urothelial bladder cancer
    Meeting Abstract

    Massard, C.; Gordon, M. S.; Sharma, S.; Rafii, S.; Wainberg, Z. A.; Luke, J. J.; Curiel, T. J.; Colon-Otero, G.; Hamid, O.; Sanborn, R. E.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase 1b/2 study of intratumoral Ad-RTS-hIL-12 + veledimex in patients with chemotherapy-responsive locally advanced or metastatic breast cancer
    Meeting Abstract

    McArthur, H. L.; Page, D. B.; Proverbs-Singh, T. A.; Solomon, S. B.; Hudis, C. A.; Norton, L.; Patil, S.; Barrett, J. A.; Lebel, F. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save